A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial ...

John Obaro, group managing director (GMD) of SystemSpecs, says the company remains dedicated to developing technology ...

Leaders hold the unique ability to inspire, influence, and guide companies toward practices that benefit not only their bottom line but also the environment and society ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A Federal High Court on Wednesday set aside its Mareva orders that froze $225.8 million in assets and accounts linked ...

In today's episode of Fratello Talks, the guys discuss this year's LVMH Watch Week ✓ Tune in to hear about all the new releases! ✓ ...

Six of the injunctive orders made by Justice Dipeolu J on December 30 last year against General Hydrocarbons Limited (GHL), publisher ...